Literature DB >> 22531846

A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.

Peng Quan1, Kai Shi, Hongze Piao, Hongyu Piao, Na Liang, Dengning Xia, Fude Cui.   

Abstract

In this study, chitosan, a cationic polymer with positive charge, was introduced to modify the nanocrystals of nitrendipine with negative charge. The nanocrystals were prepared via precipitation-high pressure homogenization method. Then the nanocrystals were dispersed into chitosan solution, and the free chitosan was removed by centrifugation to obtain the chitosan modified nanocrystals, which remained the same particle size. However, the zeta-potential changed to positive after modification. The physical stability of the chitosan modified nanocrystals was remarkably improved under ambient conditions. During the in vitro dissolution test, the modified nanocrystals showed a certain degree of slow-release property. In the in vivo study, the C(max) of nitrendipine remained the same, however, the T(max) delayed from 0.75 h to 1.5 h with the chitosan modified nanocrystals. The surface modification by chitosan improved the bioavailability compared with the initial nanocrystals, which had demonstrated significant improvement of bioavailability compared to the traditional coarse powder form. Based on the experimental results, modification of the nanocrystals with certain polymer was supposed to be a good method to control the in vitro and in vivo behaviors of the nanocrystals, which could further increase the bioavailability of the water insoluble drug.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531846     DOI: 10.1016/j.ijpharm.2012.04.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.

Authors:  Yuan He; Deng-ning Xia; Qiu-xia Li; Jin-song Tao; Yong Gan; Chi Wang
Journal:  Acta Pharmacol Sin       Date:  2015-08-10       Impact factor: 6.150

2.  Improving Oral Bioavailability of Luteolin Nanocrystals by Surface Modification of Sodium Dodecyl Sulfate.

Authors:  Jiali Liu; Yongbing Sun; Meng Cheng; Qiaoming Liu; Wan Liu; Chao Gao; Jianfang Feng; Yi Jin; Liangxing Tu
Journal:  AAPS PharmSciTech       Date:  2021-04-14       Impact factor: 3.246

Review 3.  Progress and Principle of Drug Nanocrystals for Tumor Targeted Delivery.

Authors:  Meng Bai; Mingshi Yang; Junbo Gong; Hui Xu; Zhenping Wei
Journal:  AAPS PharmSciTech       Date:  2021-12-28       Impact factor: 3.246

4.  Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation.

Authors:  Tarek A Ahmed
Journal:  Int J Nanomedicine       Date:  2016-02-02

Review 5.  Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs.

Authors:  Mayank Sharma; Rajesh Sharma; Dinesh Kumar Jain
Journal:  Scientifica (Cairo)       Date:  2016-04-30

6.  Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.

Authors:  Ahmed N Allam; Sherif I Hamdallah; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2017-07-04

Review 7.  Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles.

Authors:  Prachi B Shekhawat; Varsha B Pokharkar
Journal:  Acta Pharm Sin B       Date:  2016-11-02       Impact factor: 11.413

8.  Quality by Design Optimization of Cold Sonochemical Synthesis of Zidovudine-Lamivudine Nanosuspensions.

Authors:  Bwalya A Witika; Vincent J Smith; Roderick B Walker
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

Review 9.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

10.  Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects.

Authors:  Noriaki Nagai; Fumihiko Ogata; Hiroko Otake; Naohito Kawasaki
Journal:  Pharmaceutics       Date:  2020-04-01       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.